CPRX FY 2017 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$45,689

Operating Income

-$19M

Net Income

-$18M

EPS (Diluted)

$-0.21

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$85M

Total Liabilities

$4M

Stockholders' Equity

$81M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$45,689	-$43,406	-5.3%
Operating Income	-$19M	-$19M	+3.1%
Net Income	-$18M	-$18M	-1.9%